Mitsudomi T - Search Results

1

LKB1 gene mutations in Japanese lung cancer patients.

Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T. Onozato R, et al. Among authors: mitsudomi t. Cancer Sci. 2007 Nov;98(11):1747-51. doi: 10.1111/j.1349-7006.2007.00585.x. Epub 2007 Aug 16. Cancer Sci. 2007. PMID: 17711506 Free PMC article.

2

Molecular lesions as targets for diagnosis and therapy of lung cancer.

Mitsudomi T. Mitsudomi T. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:112-6. Gan To Kagaku Ryoho. 2002. PMID: 11890096

3

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T. Mizuno K, et al. Among authors: mitsudomi t. Oncogene. 2002 Apr 4;21(15):2328-33. doi: 10.1038/sj.onc.1205402. Oncogene. 2002. PMID: 11948416

4

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.

Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T. Koshikawa K, et al. Among authors: mitsudomi t. Oncogene. 2002 Apr 25;21(18):2822-8. doi: 10.1038/sj.onc.1205405. Oncogene. 2002. PMID: 11973641

5

TTF-1 expression in pulmonary adenocarcinomas.

Yatabe Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: mitsudomi t. Am J Surg Pathol. 2002 Jun;26(6):767-73. doi: 10.1097/00000478-200206000-00010. Am J Surg Pathol. 2002. PMID: 12023581

6

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: mitsudomi t. Oncogene. 2002 Nov 28;21(54):8310-9. doi: 10.1038/sj.onc.1206014. Oncogene. 2002. PMID: 12447694

7

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: mitsudomi t. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755

8

Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression.

Hanai T, Yatabe Y, Nakayama Y, Takahashi T, Honda H, Mitsudomi T, Kobayashi T. Hanai T, et al. Among authors: mitsudomi t. Cancer Sci. 2003 May;94(5):473-7. doi: 10.1111/j.1349-7006.2003.tb01467.x. Cancer Sci. 2003. PMID: 12824896 Free PMC article.

9

Expression of cancer/testis (CT) antigens in lung cancer.

Tajima K, Obata Y, Tamaki H, Yoshida M, Chen YT, Scanlan MJ, Old LJ, Kuwano H, Takahashi T, Takahashi T, Mitsudomi T. Tajima K, et al. Among authors: mitsudomi t. Lung Cancer. 2003 Oct;42(1):23-33. doi: 10.1016/s0169-5002(03)00244-7. Lung Cancer. 2003. PMID: 14512184

10

The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status.

Suzuki T, Nakagawa T, Endo H, Mitsudomi T, Masuda A, Yatabe Y, Sugiura T, Takahashi T, Hida T. Suzuki T, et al. Among authors: mitsudomi t. Lung Cancer. 2003 Oct;42(1):35-41. doi: 10.1016/s0169-5002(03)00278-2. Lung Cancer. 2003. PMID: 14512185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters